Results Overall and sex-specific associations of genetically predicted l-carnitine with CVD Genetically predicted higher l-carnitine was nominally associated with higher risk of CAD and heart failure in men and women, with odds ratio (OR) 1.07 (95% confidence interval (CI) 1.02 to 1.11) for CAD and OR 1.05 (95% CI 1.01 to 1.09) for heart failure per standard deviation (SD) increase in genetically predicted l-carnitine (Fig
Meta-analyses have demonstrated that GLP1RA, especially semaglutide, are superior in glycemic control, body weight reduction, and CV events compared to other methods 41,42
As well as telling the pancreas to produce more insulin (hence why the drug is given to diabetics), GLP-1 also suppresses appetite, making us feel full
It belongs to a class of medications called GLP-1 receptor agonists, which work by mimicking the action of a hormone called glucagon-like peptide-1 (GLP-1) that is naturally produced by the body
Basic injection logging: Keep a simple record, though less comprehensive than MeAgain
Both have seen remarkable growth driven by the success of their diabetes and obesity treatments